If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £65.92m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Circ re. Enhanced Buyback Scheme

21 Sep 2012 14:17

RNS Number : 8878M
Maven Income and Growth VCT 3 PLC
21 September 2012
 

MAVEN INCOME & GROWTH VCT 3 PLC

PUBLICATION OF CIRCULAR

Summary

The board of directors ("Board") of Maven Income & Growth VCT 3 plc ("the Company") is today sending out a circular ("Circular") to shareholders in relation to the proposed enhanced buyback scheme in respect of the ordinary shares of 10p each in thecapital of the Company ("Shares"), such scheme being for up to 14.99% of the issued share capital of the Company ("Enhanced Buyback Scheme").

 

The Enhanced Buyback Scheme is subject to shareholder approval being provided at a general meeting convened for 16 October 2012pursuant to the Circular. The Enhanced Buyback Scheme has opened today for application.

Enhanced Buyback Scheme

The Company is offering to purchase up to a maximum of 4,708,596 existing Shares, which represent 14.99% of the issued share capital as at 21 September 2012, subject to the proceeds of sale being reinvested in new Shares.

The record date to be eligible to participate in the Enhanced Buyback Scheme is 5.00 p.m. on 21 September 2012.

The closing date for applications pursuant to the Enhanced Buyback Scheme is 12.00 noon on 29 October 2012.

If the Enhanced Buyback Scheme is over subscribed, applications will be scaled back and accepted as follows:

Firstly, valid applications from all shareholders eligible to participate would be accepted to the extent that the number of Existing Shares to be purchased represent 14.99% or less of their holding of Existing Shares on 21September 2012 (rounded down to the nearest whole number of Existing Shares) and secondly, valid applications thereafter would be accepted pro rata to the number of Existing Shares tendered, subject always to the Board's discretion.

Further details on the Enhanced Buyback Scheme, including the terms and conditions and tax consequences of participating, are set out in the Circular and application form. Shareholders are further advised to consult their independent financial adviser.

Availability of Documents

The Circular has been submitted to the Financial Services Authority and will shortly be available for inspection both at the National Storage Mechanism, which is located at:

 

http://www.hemscott.com/nsm.do

 

and the Company's website:

 

http://www.mavencp.com/migvct3

 

Rosemary O'Neil

Maven Capital Partners UK LLP

0141 306 7400

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CIRUAAORUNAKUAR
Date   Source Headline
23rd Mar 20225:05 pmRNSIssue of Equity
21st Mar 20222:59 pmRNSPublication of Suppl.Prospcts
11th Mar 202211:35 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
7th Mar 20226:32 pmRNSAnnual Financial Report
22nd Feb 20222:27 pmRNSTransaction in Own Shares
18th Feb 20225:48 pmRNSIssue of Equity - Replacement Announcement
7th Feb 20221:53 pmRNSDirector/PDMR Shareholding
7th Feb 20221:52 pmRNSDirector/PDMR Shareholding
7th Feb 20221:50 pmRNSDirector/PDMR Shareholding
7th Feb 20221:48 pmRNSDirector/PDMR Shareholding
7th Feb 20221:47 pmRNSDirector/PDMR Shareholding
7th Feb 20221:46 pmRNSDirector/PDMR Shareholding
7th Feb 202210:50 amRNSIssue of Equity
4th Feb 20229:45 amRNSStatement re NAV and Final Dividend
31st Jan 20224:25 pmRNSStatement re Offer for Subscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
24th Nov 20214:45 pmRNSTransaction in Own Shares
29th Oct 202112:44 pmRNSNet Asset Value(s)
20th Oct 20214:46 pmRNSResult of General Meeting
20th Sep 20215:21 pmRNSPublication of a Prospectus
20th Sep 20214:57 pmRNSStatement re Change of Registrar
10th Sep 202112:34 pmRNSIssue of Equity
7th Sep 20213:08 pmRNSStatement re Dividend Investment Scheme
16th Aug 20214:08 pmRNSTransaction in Own Shares
13th Aug 20212:13 pmRNSHalf-year Report
5th Aug 20214:39 pmRNSTransaction in Own Shares
3rd Aug 202111:31 amRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
16th Apr 202110:25 amRNSIssue of Equity
15th Apr 20214:30 pmRNSTransaction in Own Shares
13th Apr 20212:22 pmRNSStatement re Dividend Investment Scheme
12th Apr 20219:00 amRNSNet Asset Value(s)
7th Apr 202112:28 pmRNSResult of AGM
5th Mar 20214:39 pmRNSFinal Results
29th Jan 20212:55 pmRNSTransaction in Own Shares
22nd Jan 20213:17 pmRNSNAV and Proposed Final Dividend
17th Nov 20204:29 pmRNSTransaction in Own Shares
16th Nov 20204:55 pmRNSTransaction in Own Shares
11th Nov 20204:58 pmRNSNet Asset Value(s)
28th Aug 202010:28 amRNSIssue of Equity
26th Aug 20205:23 pmRNSTransaction in Own Shares
21st Aug 20204:10 pmRNSStatement re NAV and DIS
29th Jul 20204:45 pmRNSTransaction in Own Shares
28th Jul 20204:44 pmRNSTransaction in Own Shares
24th Jul 20203:23 pmRNSHalf-year Report
9th Jul 202010:00 amRNSIssue of Equity
29th Jun 20205:25 pmRNSStatement re NAV and Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.